Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Denver, Colorado
- Most recent report
- 10-K, filed Sep 22, 2026
- Incorporated
- Delaware
- Filings on record
- 905 filings
- On EDGAR
- CIK 1385818
- Fiscal year ends
- June
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 78
News 8 of 233
- 8-K Quarterly results Sep 22, 2026
- 8-K Current report on a material event Jun 25, 2026
- 8-K Quarterly results May 13, 2026
- 8-K Quarterly results Apr 2, 2026
- 8-K Quarterly results Feb 3, 2026
- 8-K Current report on a material event Jan 20, 2026
- 8-K Shareholder vote results Dec 10, 2025
- 8-K Quarterly results Nov 13, 2025
Prospectuses and Registrations 8 of 127
- S-8 Registration statement for an employee plan Sep 23, 2025
- 424B4 Final prospectus for an offering Jun 9, 2025
- S-1/A Registration statement for an offering, amended Jun 5, 2025
- S-1 Registration statement for an offering Jun 2, 2025
- S-3/A Shelf registration statement, amended Oct 11, 2024
- S-3 Shelf registration statement Sep 26, 2024
- S-8 Registration statement for an employee plan Jun 23, 2023
- 424B4 Final prospectus for an offering Jun 12, 2023
Proxies 8 of 39
- DEFA14A Extra proxy material Oct 24, 2025
- DEF 14A Proxy statement for a shareholder vote Oct 24, 2025
- DEFA14A Extra proxy material Mar 28, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 28, 2025
- DEFA14A Extra proxy material May 10, 2024
- DEF 14A Proxy statement for a shareholder vote May 10, 2024
- DEFA14A Extra proxy material Apr 7, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2023
Ownership 8 of 258
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Jul 30, 2026
- 4 Insider reported a trade Jul 30, 2026
- 4 Insider reported a trade Jul 30, 2026
- 4 Insider reported a trade Jul 30, 2026
- 4 Insider reported a trade Jul 30, 2026
- 4 Insider reported a trade Jul 30, 2026
- 4 Insider reported a trade Jul 30, 2026
Other 8 of 170
- ARS Annual report sent to shareholders Oct 24, 2025
- S-1MEF Jun 6, 2025
- EFFECT Notice that a registration became effective Jun 5, 2025
- CORRESP Reply to SEC staff Jun 2, 2025
- CORRESP Reply to SEC staff Jun 2, 2025
- UPLOAD Comment letter from SEC staff May 1, 2025
- DRS Draft registration statement, submitted confidentially Apr 28, 2025
- ARS Annual report sent to shareholders Mar 28, 2025
Everything here comes from Aytu Biopharma, Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.